Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folate and B12 for Schizophrenia with Residual Symptoms in Ethiopia
NCT01724476Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2014
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of folic acid, vitamin b12 in schizophrenia, sponsored by Massachusetts General Hospital. Started Dec 2014; status: completed.
02
Drugs
folic acidvitamin b12
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01724476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724476.